Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 3,208 $ 10,233
Adjustments to reconcile net income to net cash provided by operating activities:    
Unrealized foreign currency exchange loss (gain), net 4 (2)
Depreciation and amortization expense 912 892
Share-based compensation expense 140 128
Amortization of discount and debt issuance costs 32 34
Reduction of right-of-use assets 500 464
Loss (gain) on modification or extinguishment of debt 9 (15)
Total gains on derivative instruments, net (861) (6,839)
Net cash used for settlement of derivative instruments 0 (96)
Deferred taxes 93 2,015
Other, net 14 3
Changes in operating assets and liabilities:    
Trade and other receivables 427 1,134
Inventory 50 422
Margin deposits (85) 61
Other non-current assets (55) (35)
Accounts payable and accrued liabilities (207) (1,261)
Total deferred revenue 24 27
Total operating lease liabilities (489) (456)
Other, net 37 (11)
Net cash provided by operating activities 3,753 6,698
Cash flows from investing activities    
Property, plant and equipment, net (1,669) (1,430)
Investment in equity method investments (12) (36)
Other (25) (12)
Net cash used in investing activities (1,706) (1,478)
Cash flows from financing activities    
Proceeds from issuances of debt 2,725 1,397
Redemptions, repayments and repurchases of debt (3,171) (2,548)
Distributions to non-controlling interest (648) (764)
Payments related to tax withholdings for share-based compensation (45) (62)
Repurchase of common stock (1,981) (1,132)
Dividends to stockholders (300) (291)
Other, net (73) (26)
Net cash used in financing activities (3,493) (3,426)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents (3) 2
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents (1,449) 1,796
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period 4,525 2,487
Cash, cash equivalents and restricted cash and cash equivalents—end of period $ 3,076 $ 4,283